In ₹ Crore except Per Share Latest Annual | MANGALAM FY26 | BIOFILCHEM FY26 | LASA FY26 | VINEETLAB FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | ◆ 21.05× | — | 36.00× | 28.53× | |
| P/B | ◆ 0.54× | 2.72× | 0.69× | 1.52× | 1.52× -65% | |
| EV/EBITDA | ◆ -10.74× | 94.77× | -1.54× | 11.53× | 11.53× -193% | |
| Market Cap | ₹55.2 Cr | ₹58.6 Cr | ₹34.2 Cr | ₹69.2 Cr | ₹58.6 Cr -6% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | ◆ -1.85% | -42.11% | -34.59% | -34.59% | |
| Revenue CAGR 5Y | — | ◆ -4.50% | -34.11% | -24.58% | -24.58% | |
| Net Income CAGR 3Y | — | ◆ 70.67% | — | 8.59% | 39.63% | |
| Revenue YoY (latest Q) | -0.40% | ◆ 91.99% | -93.87% | 34.21% | 34.21% -101% | |
| Net Income YoY (latest Q) | 44.64% | -95.47% | 83.05% | ◆ 111.58% | 83.05% -46% | |
| Profitability | ||||||
| EBITDA Margin | -6.42% | 2.29% | -112.98% | ◆ 14.27% | 2.29% -380% | |
| Net Income Margin | -19.13% | ◆ 9.81% | -135.60% | 2.70% | 2.70% -809% | |
| Return on Common Equity | -43.08% | ◆ 12.92% | -68.70% | 3.52% | 3.52% -1324% | |
| Return on Capital Employed | -27.98% | 1.70% | -69.54% | ◆ 10.55% | 1.70% -1746% | |
| Return on Assets | -14.10% | ◆ 6.50% | -51.44% | 1.29% | 1.29% -1193% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 1.02× | ◆ 0.14× | 0.20× | 0.99× | 0.20× +410% | |
| Interest Coverage | -2.04× | ◆ 37.37× | -89.13× | 1.24× | 1.24× -265% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹232 Cr | ₹28.4 Cr | ₹25.1 Cr | ₹59.4 Cr | ₹28.4 Cr +718% | |
| Net Income | −₹44.4 Cr | ₹2.8 Cr | −₹34.1 Cr | ₹1.6 Cr | ₹1.6 Cr -2868% | |
| Total Assets | ₹315 Cr | ₹42.8 Cr | ₹66.3 Cr | ₹125 Cr | ₹66.3 Cr +375% | |
| EPS | ₹-28.05 | ₹1.71 | ₹-6.8 | ₹1 | ₹1 -2905% | |
| Book Value per Share | ₹65.11 | ₹13.25 | ₹9.9 | ₹23.74 | ₹13.25 +391% | |